UK medicines agency set to lose lucrative EMA work post-Brexit
Agency already working on how to share post-Brexit workload.
X
UK medicines agency set to lose lucrative EMA work post-Brexit
https://pharmaphorum.com/news/ema-expects-uk-march-2019/
ema
Life sciences watches closely as Brexit negotiations loom
PM finally sets date for Brexit.
Patient power in Europe – more work to be done
What the EMA and pharma can do to promote patient involvement in decision making.
Brexit could delay drug launches, former MHRA chief warns
Britain will be in “second or third tier” of drug launches, experts warn.
Could UK’s post-Brexit regulator evaluate value as well?
But longer-term benefits could include faster reimbursement decisions.
Hunt under pressure over plans to quit EMA
Britain could be in “second rank” of medicines access, warn MPs.
EU drug regulators concerned about Brexit impact
European regulators concerned over impact of EMA move.